These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33409701)

  • 21. Discordance Between Hemoconcentration and Clinical Assessment of Decongestion in Acute Heart Failure.
    Darawsha W; Chirmicci S; Solomonica A; Wattad M; Kaplan M; Makhoul BF; Abassi ZA; Azzam ZS; Aronson D
    J Card Fail; 2016 Sep; 22(9):680-8. PubMed ID: 27079674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia.
    Soetjoadi H; Friska D; Siswanto BB; Muliawan HS
    Glob Heart; 2022; 17(1):60. PubMed ID: 36051319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure.
    Nogi K; Ueda T; Nakamura T; Nogi M; Ishihara S; Nakada Y; Hashimoto Y; Nakagawa H; Nishida T; Seno A; Onoue K; Watanabe M; Saito Y
    J Am Heart Assoc; 2023 Jan; 12(1):e025596. PubMed ID: 36583422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X" Really Mark the Spot?
    Logan JK; Mentz RJ
    Curr Heart Fail Rep; 2019 Dec; 16(6):250-256. PubMed ID: 31741230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
    Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
    Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Optimal Plasma Volume Status in Heart Failure in Relation to Clinical Outcome.
    Martens P; Nijst P; Dupont M; Mullens W
    J Card Fail; 2019 Apr; 25(4):240-248. PubMed ID: 30528705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated plasma volume is not a robust indicator of the severity of congestion in patients with heart failure.
    Çetin Güvenç R; Güvenç TS; Akıl MA; Bekar L; Vural MG; Yılmaz MB
    Am J Med Sci; 2023 Nov; 366(5):374-382. PubMed ID: 37640264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into combinational drug therapy to manage congestion in heart failure.
    Verbrugge FH; Grieten L; Mullens W
    Curr Heart Fail Rep; 2014 Mar; 11(1):1-9. PubMed ID: 24218088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure.
    Ter Maaten JM; Kremer D; Demissei BG; Struck J; Bergmann A; Anker SD; Ng LL; Dickstein K; Metra M; Samani NJ; Romaine SPR; Cleland J; Girerd N; Lang CC; van Veldhuisen DJ; Voors AA
    Eur J Heart Fail; 2019 Jun; 21(6):732-743. PubMed ID: 30843353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT.
    Grodin JL; Philips S; Mullens W; Nijst P; Martens P; Fang JC; Drazner MH; Tang WHW; Pandey A
    Eur J Heart Fail; 2019 May; 21(5):634-642. PubMed ID: 30714658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of Estimated Plasma Volume at Postdischarge Follow-Up to Predict Recurrent Events in Patients With Heart Failure.
    Balderston JR; Shah KB; Paciulli SC; Gertz ZM
    Am J Cardiol; 2018 Oct; 122(7):1191-1194. PubMed ID: 30241666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decongestion in acute heart failure.
    Mentz RJ; Kjeldsen K; Rossi GP; Voors AA; Cleland JG; Anker SD; Gheorghiade M; Fiuzat M; Rossignol P; Zannad F; Pitt B; O'Connor C; Felker GM
    Eur J Heart Fail; 2014 May; 16(5):471-82. PubMed ID: 24599738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Dovancescu S; Pellicori P; Mabote T; Torabi A; Clark AL; Cleland JGF
    Eur J Heart Fail; 2017 May; 19(5):643-649. PubMed ID: 28295907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?
    Cuthbert JJ; Pellicori P; Rigby AS; Abel AAI; Kalvickbacka-Bennet A; Shah P; Kearsley JW; Kazmi S; Cleland JGF; Clark AL
    Eur Heart J Qual Care Clin Outcomes; 2023 Apr; 9(3):281-292. PubMed ID: 35723241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
    Selvaraj S; Claggett B; Pozzi A; McMurray JJV; Jhund PS; Packer M; Desai AS; Lewis EF; Vaduganathan M; Lefkowitz MP; Rouleau JL; Shi VC; Zile MR; Swedberg K; Solomon SD
    Circulation; 2019 Oct; 140(17):1369-1379. PubMed ID: 31510768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
    Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
    Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients.
    Ahmad T; Lund LH; Rao P; Ghosh R; Warier P; Vaccaro B; Dahlström U; O'Connor CM; Felker GM; Desai NR
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.